Dr Liz Smaill is Chief Executive Officer at Optimal Clinical Trials, part of the NZCR Group, a phase 1 to 4 clinical research organisation across ANZ. With a background in medicine and deep experience across commercial Phase 1b–3 trials, Liz is passionate about improving everyday lives through high‑quality, patient‑centred research. She works closely with global pharmaceutical companies, CROs, and biotech partners and is recognised for driving speed, quality, and strong site–sponsor collaboration.
